Citigroup
ANIP icon

Citigroup’s ANI Pharmaceuticals ANIP Stock Holding History

Citigroup’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$6K – 6220
2020
Q4 		$6K Sell
200
-400
-67% -$11.5K ﹤0.01% 7067
2020
Q3 		$17K Buy
600
+400
+200% +$11.9K ﹤0.01% 6287
2020
Q2 		$6K Sell
200
-1,500
-88% -$53.8K ﹤0.01% 7206
2020
Q1 		$69K Hold
1,700
– – ﹤0.01% 5666
2019
Q4 		$105K Buy
1,700
+1,400
+467% +$92.7K ﹤0.01% 5733
2019
Q3 		$22K Sell
300
-200
-40% -$15K ﹤0.01% 6668
2019
Q2 		$41K Buy
500
+400
+400% +$28.4K ﹤0.01% 6640
2019
Q1 		$7K Sell
100
-4,000
-98% -$235K ﹤0.01% 7329
2018
Q4 		$185K Sell
4,100
-200
-5% -$10.5K ﹤0.01% 5091
2018
Q3 		$243K Buy
4,300
+4,200
+4,200% +$257K ﹤0.01% 5043
2018
Q2 		$7K Buy
+100
New +$6.24K ﹤0.01% 7264
2018
Q1 		– Sell
-4,200
Closed -$271K – 7520
2017
Q4 		$271K Buy
4,200
+2,200
+110% +$137K ﹤0.01% 4756
2017
Q3 		$105K Sell
2,000
-2,000
-50% -$95.4K ﹤0.01% 5526
2017
Q2 		$187K Sell
4,000
-4,700
-54% -$227K ﹤0.01% 4855
2017
Q1 		$431K Buy
8,700
+2,000
+30% +$112K ﹤0.01% 3999
2016
Q4 		$406K Buy
6,700
+5,800
+644% +$355K ﹤0.01% 4597
2016
Q3 		$60K Buy
+900
New +$56.3K ﹤0.01% 5542

Other funds holding ANIP

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Mizuho Markets Americas
Mizuho Markets Americas New York $6.82B AUM 29.92% 1-Year Est. Return

Citigroup's ANIP Position: Q3 2026 in Review

Citigroup increased its ANI Pharmaceuticals (ANIP) stake by 13% in Q3 2026, buying an estimated $1.37M and bringing the position to 154,160 shares worth $11.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Citigroup first reported a position in ANIP in Q2 2013 and has held it in 51 quarters since. The position peaked at $13.6M in Q4 2025. 147 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Citigroup held 154,160 shares of ANI Pharmaceuticals worth $11.2M as of Q3 2026.
  • Citigroup bought 17,749 ANI Pharmaceuticals shares in Q3 2026, an estimated $1.37M.
  • ANI Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #1545 holding.
  • Citigroup first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Citigroup's ANI Pharmaceuticals position peaked at $13.6M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.